<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7256539\results\search\zoonosis\results.xml">
  <result pre="centre remains active. Abstract Given the rapid spread of the" exact="coronavirus disease 2019" post="(COVID-19) pandemic and its overwhelming effect on health care"/>
  <result pre="Ang II, angiotensin II AT1R, type 1 angiotensin receptor COVID-19," exact="coronavirus disease 2019" post="IL-1/6/8, interleukin-1/6/8 NF-ÎºB, nuclear factor ÎºB SARS-CoV-2, severe acute"/>
  <result pre="acute respiratory syndrome coronavirus 2 TNF-Î±, tumor necrosis factor Î±" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) continues to rapidly spread worldwide. To"/>
  <result pre="worldwide. To date, no specific therapeutic agents or vaccines for" exact="coronavirus disease 2019" post="(COVID-19) are available, and much information on the causative"/>
  <result pre="well as in both the 2003 SARS-CoV and the 2012" exact="Middle East respiratory syndrome" post="epidemics, women have substantially lower case-fatality rates than do"/>
  <result pre="had a worse prognosis than did female mice. Specifically, after" exact="SARS-CoV infection," post="male mice had higher viral titers, more pulmonary vascular"/>
  <result pre="COVID-19. References References 1WuZ.McGooganJ.M.Characteristics of and important lessons from the" exact="coronavirus disease 2019" post="(COVID-19) outbreak in China: summary of a report of"/>
  <result pre="perspectives on immune responsesCell Death Differ27520201451145432205856 12de JongM.D.SimmonsC.P.ThanhT.T.Fatal outcome of" exact="human influenza" post="A (H5N1) is associated with high viral load and"/>
  <result pre="increased risk for COVID-19 infection?Lancet Respir Med842020e2132171062 33SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a review [published online ahead of print April"/>
 </snippets>
</snippetsTree>
